Clinical trials: Metastatic Hormonesensitive Prostate Cancer (mHSPC)
Metastatic Hormonesensitive Prostate Cancer (mHSPC)
An Observational Study to Learn More About How Medicines That Block Male Hormones Are Used in People With Prostate Cancer in Australia
This is a retrospective, observational study looking at real-world prescription data in Australia. The study focuses on adult men with metastatic hormone-sensitive prostate cancer (mHSPC), a type of prostate cancer that has…
- Trial name
- TARA (NCT07223372)
- Where
- Australia
- Volunteers
- 1,000 people
- Sponsor
- Bayer